CDKN2A and lung adenocarcinoma: Although widespread aneuploidy is typically regarded as a hallmark of advanced cancer stages (Ben-David and Amon 2019), specific copy number changes, like CDKN2A deletions, have been documented to sometimes occur early in lung adenocarcinoma development (Nahar et al. 2018, Watkins et al. 2020).